Anti-GD2 Monoclonal Antibody1vial

(S)-3-((tert-Butoxycarbonyl)amino)-4-hydroxybutanoic acid, 95.0%, 250mg

(2-Fluoro-4-(methylcarbamoyl)phenyl)boronic acid, 95+%, 1g

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 5g

Bottle-top filters with SFCA membrane Pore size 0.2 μm, 1000 ml, 90 mm, 12 Piece(s)

3-Fluoro-4-methoxybenzonitile, 97.0%, 25g

Methyl 3-amino-2,2-dimethylpropanoate hydrochloride, 95.0%, 1g

2-Amino-5-trifluoromethyl-1,3,4-thiadiazole>98.0%(HPLC)25g

5-(1,3-Dioxolan-2-yl)-2-(4-hexyloxybenzoyl)thiophene, 97.0%, 1g

4-Methylcyclohexylamine (cis- and trans- mixture)>99.0%(GC)5mL

Methyl 4'-bromomethyl-biphenyl-2-carboxylate, 95.0%, 25g

(S)-4-Benzyl-3-hydroxymethylmorpholine, 97.0%, 10g

2-Chloro-5-(trifluoromethyl)benzyl Alcohol>98.0%(GC)5g